Celcuity Inc. and its peers
1 companies side by side: each figure with its date and source, its rank in the group and its percentile in its sector and country.
Companies in the group
Up to 12. Remove or re-base from the table's column heads.
Keep this group
Save it for yourself or, in a team, for everyone in it.
Suggested peers of Celcuity Inc.#
Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.
- CareDx, IncCDNA · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $3.4 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $3.4 B (Oct 19, 2026) · revenue $380 M (year to December 2025)100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)+ Add
- Vitaspring Biomedical Co. Ltd.VSBC · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $3.1 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $3.1 B (last known, Jan 5, 2024)99 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)+ Add
- Neogen CorporationNEOG · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $2.6 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $2.6 B (Oct 23, 2026) · revenue $870 M (year to May 2026)98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)+ Add
- BillionToOne, Inc.BLLN · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $5.1 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $5.1 B (Oct 1, 2026) · revenue $305 M (year to December 2025)98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)+ Add
- Sotera Health CompanySHC · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $5.2 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $5.2 B (Sep 24, 2026) · revenue $1.2 B (year to December 2025)98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)+ Add
- Grail, Inc.GRAL · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $5.3 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $5.3 B (Oct 19, 2026) · revenue $147 M (year to December 2025)97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)+ Add
- NeoGenomics, Inc.NEO · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $2.2 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $2.2 B (Oct 15, 2026) · revenue $727 M (year to December 2025)97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)+ Add
- RadNet, Inc.RDNT · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $5.8 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $5.8 B (Oct 28, 2026) · revenue $2.0 B (year to December 2025)97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)+ Add
- Caris Life Sciences, Inc.CAI · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $6.2 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $6.2 B (Aug 1, 2026) · revenue $812 M (year to December 2025)96 of 100 (industry or sector 50 + size 26 + country 15 + figures on file 5)+ Add
- Fortrea Holdings Inc.FTRE · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $2.0 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $2.0 B (Oct 9, 2026) · revenue $2.7 B (year to December 2025)96 of 100 (industry or sector 50 + size 26 + country 15 + figures on file 5)+ Add
- Lantheus Holdings, Inc.LNTH · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $6.5 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $6.5 B (Oct 26, 2026) · revenue $1.5 B (year to December 2025)96 of 100 (industry or sector 50 + size 26 + country 15 + figures on file 5)+ Add
- Freenome, Inc.FRNM · 🇺🇸 USASame industry: Diagnostics and Research · Similar size: $1.7 B market cap against $3.5 B · Same country: USA · Ratios of the last two fiscal years on fileMarket cap $1.7 B (Oct 2, 2026)95 of 100 (industry or sector 50 + size 25 + country 15 + figures on file 5)+ Add
Side by side#
Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.
| Measure | Celcuity Inc.base CELC · 🇺🇸 US Percentile in Healthcare Percentile in USA | Group median |
|---|---|---|
| Size | ||
| Market cap (Better neither way: ranked highest first) | $3.5 BOct 5, 2026 · Market dataonly one with it | $3.5 B— |
| Net income (Higher is better) | $-177 MFY2025 · SEConly one with it | $-177 M— |
| Employees (Better neither way: ranked highest first) | 155December 31, 2025 · Profileonly one with it | 155— |
| Margins and returns | ||
| Return on equity (Higher is better) | -163.8%FY2025 · SEConly one with it14th6th | -163.8%— |
| Valuation | ||
| Price to book (Better neither way: ranked highest first) | 35.2×price Oct 5, 2026 · Market dataonly one with it96th98th | 35.2×— |
| Free cash flow yield (Higher is better) | -4.3%price Oct 5, 2026 · Market dataonly one with it56th28th | -4.3%— |
| Financial strength | ||
| Debt to equity (Lower is better) | 1.4×FY2025 · SEConly one with it83rd77th | 1.4×— |
| Interest cover (Higher is better) | -12.0×FY2025 · SEConly one with it40th20th | -12.0×— |
| Scorecard | ||
| Scorecard (Higher is better) | 2 of 15FY2025 · Scorecardonly one with it | 13% passed— |
| Valuation checks (Higher is better) | 0 of 4FY2025 · Scorecardonly one with it | 0% passed— |
| Growth checks (Higher is better) | 0 of 2FY2025 · Scorecardonly one with it | 0% passed— |
| Profitability checks (Higher is better) | 0 of 3FY2025 · Scorecardonly one with it | 0% passed— |
| Financial health checks (Higher is better) | 2 of 5FY2025 · Scorecardonly one with it | 40% passed— |
| Shareholder returns checks (Higher is better) | 0 of 1FY2025 · Scorecardonly one with it | 0% passed— |
| Ownership | ||
| Held by institutions (Better neither way: ranked highest first) | 117.8%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are inonly one with it | 117.8%— |
| Institutions holding (Better neither way: ranked highest first) | 2692026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are inonly one with it | 269— |
| Institutional holding, change over the quarter (Better neither way: ranked highest first) | +14.9 pp2026-Q2 against 2026-Q1 · 13Fonly one with it | +14.9 pp— |
Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Celcuity Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover.
Where each stands in its sector and country: Return on equity#
The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.
| Company | Return on equity | In its sector | In its country |
|---|---|---|---|
| Celcuity Inc. | -163.8%FY2025 | 14th percentile in Healthcaremedian -36.9%, 977 companies | 6th percentile in USAmedian 4.8%, 3,580 companies |
Revenue by fiscal year, and the rank in the group#
Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).
Revenue
Fewer than two years of revenue are on file for these companies.
Rank in the group
Ranks need two fiscal years with the figure for at least two of these companies.